In mice with induced liver fibrosis, mirtazapine, also a 5-HT2A inhibitor, prevented the Smad3 phosphorylation and TGF-β expression in the liver tissue [111], although the antibody used to detect Smad3 phosphorylation was not specified. The gene discussed is SMAD3; the disease is Hepatic fibrosis.